Forecast & Rating4 analysts currently cover Outlook Therapeutics, of which 3 give a positive rating. The average price target is $5.40, about 613.9% upside from the current price of $0.76. Coverage is limited, so the data is for reference only. Data as of Aug 16, 2026; this does not constitute investment advice.
Aug 14, 2026Price forecast
$5.40613.91%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 9, 2026
Forecast met0.0%
Stock price$0.76
Avg. target$5.4
High target$10
Low target$2
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.